Reasons to attend
Do you want to understand more deeply the sponsor co-monitoring practice and how this yields benefits in clinical research?
Several sponsors have developed successful co-monitoring strategies, but do we understand how critical this is in terms of not merely CRA oversight but for the overall conduct of the clinical trial. This course provides you with the grounding that will allow you to understand the most salient aspects of co-monitoring practice.
- Documents and materials related to this course are included
- Globally recognised certificates awarded after test completion
- This course has been granted PharmaTrain Recognition
Classroom (Face to Face):
One Day face-to-face training: 09h00-17h00
2 sessions of 3 hours
Next Session: April 15 & 16 from 10h - 13h
During this course in which presentations are blended with interactive sessions with the attendees, you will receive a good oversight on regulations guiding co-monitoring, principles of CRA oversight, tools, and methodologies, and above all comprehensive guidance on how co-monitoring can improve the conduct and quality of your clinical trial.
The course will present real-life case studies and examples where either CRA performance or indeed site performance has not been adequate and will use interactive workshops to find ideal solutions. Exercises for self-assessment are used to enhance your understanding of the main topics discussed in the course. You will be able to test your comprehension with a final grading assessment.